Infection Surveillance Solutions Market

Infection Surveillance Solutions Market by Software (Cloud-based), Service (Product Support, Maintenance, Implementation), End User (Hospitals (Large, Medium-Sized, Small Hospitals) Long-Term Care Facilities), COVID-19 Impact - Global Forecast to 2026

Report Code: HIT 4380 Sep, 2021, by marketsandmarkets.com

[242 Pages Report] The infection surveillance solutions market is projected to reach USD 1,033 million by 2026 from USD 508 million in 2021, at a CAGR of 15.2%. The growth of this market is influenced primarily due to the increasing incidence of hospital-acquired infections (HAIs) and new Medicare policies, including non-payment for hospital-acquired conditions. The rising healthcare expenditure, increasing number of surgeries, growing geriatric population, and the increasing incidence of chronic diseases are the other factors driving the growth of this market. Currently, with the surge in COVID-19 cases, there is an increased focus on personal hygiene, coupled with the need to track and monitor the spread of COVID-19 infection. This is further expected to drive the market growth during the forecast period. Moreover, increasing healthcare costs, strong government support and initiatives and the growing focus on the quality of care and patient safety are further expected to support the growth of the market for infection surveillance solutions across the globe.

On the other hand, the high cost of health IT solutions deployment in small healthcare organizations in developing countries and the reluctance among medical professionals to adopt advanced healthcare IT solutions are expected to hamper the growth of this market during the forecast period.

Infection Surveillance Solutions Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on Infection Surveillance Solutions Market

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic in just a matter of a few weeks. The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 2020. According to Worldometers, there were 23.6 million confirmed COVID-19 cases globally as of August 24, 2020. Owing to this, there is a major shortage of beds, healthcare providers, and basic medical supplies in healthcare facilities. This is compelling healthcare organizations to deploy HCIT solutions, such as infection surveillance solutions, EHRs, telehealth platforms, and patient registries, to track and monitor COVID-19 infections in patients and collect data for better patient outcomes.

COVID-19 has compelled various government bodies and organizations to adopt digital technologies and healthcare IT solutions. Some of the key developments in this regard have been mentioned below: 

  • In order to combat COVID-19, the Singapore government adopted various strategies. One of the strategies was to capture the data of the entire population in the country. The strategy involved the use of surveillance technology in newly created Community Care Facilities (CCFs), while the manpower was focused on dealing with high-risk patients.
  • The Office of National Coordinator (ONC) for Health Information Technology partnered with the CDC to share various resources for reporting and tracking COVID-19, as well as to provide general clinical guidance to the healthcare IT community and healthcare providers. In the US, healthcare IT is playing a crucial role in collecting and reporting COVID-19 data.

Infection Surveillance Solutions Market Dynamics

Driver: Increasing prevalence of hospital-acquired infections

Hospital-acquired infections (HAIs) are nosocomial infections that occur during a patient’s stay at hospitals and related facilities and are not observed at the time of admission. They are a major cause of morbidity and mortality worldwide. These infections include central line-associated bloodstream infections, surgical-site infections, catheter-associated urinary tract infections, hospital-acquired pneumonia, ventilator-associated pneumonia, and Clostridium difficile infections. The most common bacteria associated with HAIs include C. difficile, MRSA, Klebsiella, E. coli, Enterococcus, and the Pseudomonas species. The use of infected medical devices during diagnostic and therapeutic procedures is a major cause of HAIs. The incidence of HAIs is mainly dependent on the immune status of patients, infection control practices, and the prevalence of various infectious agents in healthcare facilities. Other factors include longer hospital stays, immunosuppression, older age, and stays in intensive care units. Around 20% of such infections occur in ICUs. The transmission of pathogens can occur through direct contact with healthcare workers or a contaminated environment. Pathogens tend to colonize in warm and moist areas such as the inguinal and perineal areas, axilla, and trunk. Several governments and non-governmental associations such as the WHO, the Joint Commission on the Accreditation of Healthcare Organizations (JCAHO), Centers for Disease Control and Prevention (CDC), Centers for Medicare & Medicaid Services (CMS), National Accreditation Board for Hospitals & Healthcare Providers (NABH), and Association for Professionals in Infection Control and Epidemiology (APIC) are focusing on curbing the increasing incidence of HAIs.

Restraint: High cost of deployment for small healthcare organizations

The cost of interoperability and deployment of software solutions is considerably high. Smaller healthcare organizations struggle to implement internet connectivity to utilize healthcare IT solutions. This is mainly due to difficulties in implementing multiple networks with health setups, a lack of wireless connectivity options, and the need to install subsequent myriads of security layers to avoid data breaches. Infection surveillance software are high priced.  And most systems need to be customized with respect to the requirements of healthcare facilities. Moreover, support and maintenance services, which include modification and upgrading software as per the changing user requirements, represent a recurring expenditure, which accounts for a large share of the total cost of ownership. Also, post-sales custom interface development for device integration requires additional verification and validation to ensure solution accuracy and completeness. This further increases the total cost of ownership for healthcare providers. Small hospitals and healthcare organizations cannot afford these additional costs.

Opportunity: Increasing consolidation in the healthcare industry

Currently, the healthcare industry is increasingly consolidating in the US, and large regional and national healthcare systems are expanding in size. In the US, the implementation of the PPACA in 2010 has mandated healthcare organizations in the country to use advanced healthcare IT tools, which, in turn, has increased the financial burden on healthcare organizations. The implementation of such healthcare reforms affects the profit margins of hospitals, doctors, and insurers. To control healthcare delivery costs, healthcare organizations in the US are increasing their patient base and optimizing the utilization of available resources. In this regard, consolidation is one of the most preferred strategies adopted by healthcare providers to increase their patient base and optimize resource utilization. According to the American Hospital Association Survey, 2019, of the nearly 5,200 hospitals in the US, approximately 65% are part of a bigger health system.

Challenge Shortage of skilled healthcare IT professionals

The effective utilization of infection surveillance solutions demands strong IT infrastructure and IT support within the organization as well as at the solution provider’s end. In a healthcare organization, there is a continuous need for technical support for maintaining the server and network for the smooth operation of clinical workflows and optimum interfacing speed of surveillance systems. If the maintenance of the server or network is inadequate, it leads to the generation of screen loads, which slow down clinical workflows. As healthcare organizations become increasingly sophisticated with their IT initiatives, human resource leaders are experiencing a new set of hiring challenges. The shortage of qualified resources is a major barrier to implementing infection surveillance solutions in hospitals. Currently, the demand for HCIT professionals far exceeds their supply in both developing and developed markets.

The software segment is accounted for the largest share of the infection surveillance solutions market in 2020

Based on product, the infection surveillance solutions market is segmented into infection surveillance software solutions and infection surveillance services. In 2020, the infection surveillance software segment accounted for the largest share of the infection surveillance solutions market. The large share of this segment can be attributed to the increasing need for preventing HAIs and the growing number of surgical procedures

The on-premise  software segment accounted for the largest share of the infection surveillance solutions market in 2020

Based on type, the infection surveillance software market is segmented into on-premise and web-based software. In 2020, the on-premise software segment accounted for the largest share of the infection surveillance software market. The large share of this segment is mainly attributed to the need for maintaining access to healthcare IT solutions and reduce the risk of data breaches & external attacks.

The product support and maintenance services segment accounted for the largest share of the infection surveillance solutions market in 2020

Based on type, the infection surveillance services market is segmented into product support and maintenance services, training and consulting services, and implementation services. In 2020, the product support and maintenance services segment accounted for the largest share of the infection surveillance services market. Product support and maintenance services take care of interoperability and software complexity issues. These services ensure that clients (healthcare providers) obtain access to the vendor company’s technical knowledge base, gain support from its product support team, and acquire application management skills. These factors are driving the growth of the product support and maintenance services segment.

The hospitals segment accounted for the largest share of the infection surveillance solutions market in 2020

Based on end user, the infection surveillance solutions market is segmented into hospitals, long-term care facilities, and other end users. In 2020, the hospitals segment accounted for the largest share of the infection surveillance solutions market. The large share of this segment can be attributed to the large patient volume, the increasing incidence of HAIs, and the increasing cases of SSIs. The COVID-19 pandemic has also increased the adoption of infection surveillance solutions in hospitals.

North America accounted for the largest share of the infection surveillance solutions market in 2020

In 2020, North America accounted for the largest share of the infection surveillance solutions market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this region can be attributed to factors such as the growing consolidation among healthcare providers, widespread adoption of healthcare IT solutions to curtail the rising healthcare costs, increasing incidence of HAIs, and the rising number of COVID-19 patients in the US. The presence of a large number of players in the region is also a key factor contributing to the large share of North America in the infection surveillance solutions market.

Infection Surveillance Solutions Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

The prominent players in the infection surveillance solutions market include Becton, Dickinson and Company (US), Premier International, Inc. (US), Wolters Kluwer N.V. (Netherlands), Cerner Corporation (US), Baxter International Inc. (US), GOJO Industries, Inc. (US), Sunquest (US), Deb Group Ltd. (UK), BioVigil Healthcare Systems (US), RLDatix (UK), IBM Corporation (US), Vecna Technologies, Inc. (US), VigiLanz Corporation (US), Ecolab Inc. (US), Harris Healthcare (US), PeraHealth Inc. (US), Medexter Healthcare (Austria), CenTrak, Inc. (US), bioMerieux SA (France), CKM Healthcare (Canada), Asolva Inc. (US), PointClickCare (Canada), STANLEY Healthcare (US), Vitalacy Inc. (US), and Vizzia Technologies (US).

Scope of Market

Report Metric

Details

Market size available for years

2019–2026

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD Million)

Segments covered

Product & Services and End-user

Geographies covered

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

Companies covered

Becton, Dickinson and Company (US), Premier International, Inc. (US), Wolters Kluwer N.V. (Netherlands), Cerner Corporation (US), Baxter International Inc. (US), GOJO Industries, Inc. (US), Sunquest (US), Deb Group Ltd. (UK), BioVigil Healthcare Systems (US), RLDatix (UK), IBM Corporation (US), Vecna Technologies, Inc. (US), VigiLanz Corporation (US), Ecolab Inc. (US), Harris Healthcare (US), PeraHealth Inc. (US), Medexter Healthcare (Austria), CenTrak, Inc. (US), bioMerieux SA (France), CKM Healthcare (Canada), Asolva Inc. (US), PointClickCare (Canada), STANLEY Healthcare (US), Vitalacy Inc. (US), and Vizzia Technologies (US).

The study categorizes the Infection Surveillance Solutions Market based on product & services,  end user, and regional and global level.

Global Infection Surveillance Solutions Market, by Product & Services

  •  Software
    • On-Premise Software
    • Web-Based Software
  •  Services
    • Product Support & Maintenance
    • Implementation Services
    • Training & Consulting services

Global Infection Surveillance Solutions Market, by End User 

  • Hospitals
    • Large Hospitals
    • Medium Sized Hospitals
    • Small Hospitals
  • Long-Term Care Facilities
    • Nursing Homes
    • Skilled Nursing Facilities
    • Assisted- Living Facilities
  • Other End Users

Global Infection Surveillance Solutions Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia & New Zealand
    • South Korea
    • Rest of APAC
  • Latin America
  • Middle East & Africa

Recent Developments

  • In 2021, IBM Corporation (US) acquired BoxBoat (US). With this acquisition, BoxBoat will extend IBM's container strategy and implementation services portfolio to further advance IBM's hybrid cloud strategy.
  •  In 2021, bioMιrieux SA(France) launched EPISEQ SARS-CoV-2, a cloud-based surveillance software application intended to identify variants using samples from positive patients. Automatically updated each week, the platform identifies variants based on international nomenclatures, including any new variant of concern (VOC) as defined by the World Health Organization and the US Centers for Disease Control and Prevention.
  • In 2020, Wolters Kluwer(Netherlands) enhanced its infection surveillance software Sentri 7 with AI,  to identify patients at risk for Clostridioides difficile (C. diff) infection.
  • In 2020, Cerner Corporation (US) collaborated with Xealth (US), to help health systems choose, manage, and deploy digital tools and applications while offering clinicians access to remote monitoring and more direct engagement with patients.
  • In 2020, Ecolab Inc. (US) opened the Luce Letartre Research Centre in Sainghin-en-Mιlantois in the north of France. This helped accelerate its ability to launch innovations for infection prevention in the healthcare sector.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 23)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION & SCOPE
           1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
           1.2.2 MARKET SEGMENTATION
                    FIGURE 1 INFECTION SURVEILLANCE SOLUTIONS MARKET SEGMENTATION
           1.2.3 YEARS CONSIDERED FOR THE STUDY
    1.3 CURRENCY
          TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
    1.4 STAKEHOLDERS
    1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 28)
    2.1 RESEARCH APPROACH
    2.2 RESEARCH METHODOLOGY DESIGN
          FIGURE 2 INFECTION SURVEILLANCE SOLUTIONS MARKET: RESEARCH DESIGN
           2.2.1 SECONDARY RESEARCH
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY DATA
                    FIGURE 3 PRIMARY SOURCES
                    2.2.2.1 Key data from primary sources
                    2.2.2.2 Insights from primary experts
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.3 MARKET SIZE ESTIMATION: INFECTION SURVEILLANCE SOLUTIONS MARKET
          FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION
          FIGURE 8 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          FIGURE 9 CAGR PROJECTIONS
          FIGURE 10 TOP-DOWN APPROACH
    2.4 DATA TRIANGULATION APPROACH
          FIGURE 11 DATA TRIANGULATION METHODOLOGY
    2.5 MARKET RANKING ESTIMATION
    2.6 ASSUMPTIONS FOR THE STUDY
    2.7 LIMITATIONS
           2.7.1 METHODOLOGY-RELATED LIMITATIONS
           2.7.2 SCOPE-RELATED LIMITATIONS
    2.8 RISK ASSESSMENT
          TABLE 2 RISK ASSESSMENT: INFECTION SURVEILLANCE SOLUTIONS MARKET

3 EXECUTIVE SUMMARY (Page No. - 42)
    FIGURE 12 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
    FIGURE 13 INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    FIGURE 14 INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    FIGURE 15 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE INFECTION SURVEILLANCE SOLUTIONS MARKET

4 PREMIUM INSIGHTS (Page No. - 46)
    4.1 INFECTION SURVEILLANCE SOLUTIONS MARKET OVERVIEW
          FIGURE 17 GROWING INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET GROWTH
    4.2 NORTH AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE AND COUNTRY
          FIGURE 18 ON-PREMISE SOFTWARE SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2020
    4.3 INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
          FIGURE 19 CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD
    4.4 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION (2019–2026)
          FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE THE INFECTION SURVEILLANCE SOLUTIONS MARKET DURING THE FORECAST PERIOD
    4.5 INFECTION SURVEILLANCE SOLUTIONS MARKET: DEVELOPED VS. DEVELOPING MARKETS
          FIGURE 21 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 51)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          TABLE 3 MARKET DYNAMICS: INFECTION SURVEILLANCE SOLUTIONS MARKET
           5.2.1 MARKET DRIVERS
                    5.2.1.1 Growing global prevalence of COVID-19
                                TABLE 4 TOTAL NUMBER OF CONFIRMED COVID-19 CASES, BY REGION (AS OF AUGUST 23, 2021)
                    5.2.1.2 Increasing prevalence of hospital-acquired infections
                    5.2.1.3 Increasing adoption of antimicrobial stewardship programs
                    5.2.1.4 Increasing number of surgeries
                                TABLE 5 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED
                    5.2.1.5 Growing geriatric population and the increasing incidence of chronic diseases
                    5.2.1.6 Growing investments to improve healthcare systems
           5.2.2 MARKET RESTRAINTS
                    5.2.2.1 High cost of deployment for small healthcare organizations
                                TABLE 6 AVERAGE SELLING PRICE OF HEALTHCARE IT SOLUTIONS, BY PRODUCT, 2020
                    5.2.2.2 Reluctance among medical professionals to adopt advanced healthcare IT solutions
           5.2.3 MARKET OPPORTUNITIES
                    5.2.3.1 Increasing consolidation in the healthcare industry
                                FIGURE 22 US: HOSPITAL MERGERS & ACQUISITIONS, 2015–2019
                    5.2.3.2 Cloud-based software solutions
                    5.2.3.3 Emerging markets
           5.2.4 MARKET CHALLENGES
                    5.2.4.1 Shortage of skilled healthcare IT professionals
                    5.2.4.2 Data security concerns

6 INDUSTRY INSIGHTS (Page No. - 61)
    6.1 INTRODUCTION
    6.2 INDUSTRY TRENDS
           6.2.1 SHIFT TOWARD WEB-BASED SOLUTIONS
           6.2.2 AI-POWERED SURVEILLANCE SOFTWARE
           6.2.3 SHIFT TOWARD AUTOMATION IN HEALTHCARE FACILITIES
           6.2.4 INFECTION SURVEILLANCE USING MOBILE APPLICATION TOOLS
    6.3 REGULATORY ANALYSIS
           6.3.1 NORTH AMERICA
           6.3.2 EUROPE
           6.3.3 ASIA
           6.3.4 MIDDLE EAST AND AFRICA
           6.3.5 LATIN AMERICA
                    TABLE 7 KEY REGULATIONS & STANDARDS GOVERNING INFECTION SURVEILLANCE SOLUTIONS
    6.4 TECHNOLOGY ANALYSIS
           6.4.1 CLOUD COMPUTING TECHNOLOGY
           6.4.2 ARTIFICIAL INTELLIGENCE
                    TABLE 8 AI IN HEALTHCARE MARKET, BY REGION, 2017–2026 (USD MILLION)
           6.4.3 BLUETOOTH LOW ENERGY SENSORS
    6.5 ECOSYSTEM ANALYSIS
           6.5.1 HEALTHCARE IT MARKET: ECOSYSTEM ANALYSIS
           6.5.2 INFECTION SURVEILLANCE SOLUTIONS MARKET: ECOSYSTEM ANALYSIS
    6.6 PATENT ANALYSIS
           6.6.1 PATENT PUBLICATION TRENDS FOR INFECTION SURVEILLANCE SOLUTIONS
                    FIGURE 23 PATENT PUBLICATION TRENDS (JANUARY 2011–AUGUST 2021)
           6.6.2 JURISDICTION AND TOP APPLICANT ANALYSIS
                    FIGURE 24 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR INFECTION SURVEILLANCE SOLUTIONS PATENTS (JANUARY 2011–AUGUST 2021)
                    FIGURE 25 TOP APPLICANT COUNTRIES/REGIONS FOR INFECTION SURVEILLANCE SOLUTIONS PATENTS (JANUARY 2011–AUGUST 2021)
                    TABLE 9 LIST OF PATENTS/PATENT APPLICATIONS IN THE INFECTION SURVEILLANCE SOLUTIONS MARKET, 2020–2021
    6.7 IMPACT OF COVID-19 ON THE INFECTION SURVEILLANCE SOLUTIONS MARKET

7 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE (Page No. - 74)
    7.1 INTRODUCTION
          TABLE 10 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
    7.2 SOFTWARE
          FIGURE 26 INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2021–2026 (USD MILLION)
          TABLE 11 INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 12 INFECTION SURVEILLANCE SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           7.2.1 ON-PREMISE SOFTWARE
                    7.2.1.1 Data protection and in-house access to healthcare IT solutions to drive the growth of this market segment
                                TABLE 13 ON-PREMISE SOFTWARE SOLUTIONS OFFERED BY KEY MARKET PLAYERS
                                TABLE 14 ON-PREMISE INFECTION SURVEILLANCE SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           7.2.2 WEB-BASED SOFTWARE
                    7.2.2.1 Increasing demand for data centralization and cost-benefits of these solutions to drive their adoption
                                TABLE 15 WEB-BASED SOFTWARE OFFERED BY KEY MARKET PLAYERS
                                TABLE 16 WEB-BASED INFECTION SURVEILLANCE SOFTWARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    7.3 INFECTION SURVEILLANCE SERVICES
          FIGURE 27 INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)
          TABLE 17 INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 18 INFECTION SURVEILLANCE SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           7.3.1 PRODUCT SUPPORT AND MAINTENANCE SERVICES
                    7.3.1.1 Growing trend of outsourcing for healthcare IT support to drive the growth of this market segment
                                TABLE 19 PRODUCT SUPPORT & MAINTENANCE SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           7.3.2 IMPLEMENTATION SERVICES
                    7.3.2.1 The need for regulatory compliance to abide by relevant healthcare IT laws and regulations to boost the growth of this market segment
                                TABLE 20 IMPLEMENTATION SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           7.3.3 TRAINING & CONSULTING SERVICES
                    7.3.3.1 These services help end users enhance their understanding of systems and software solutions
                                TABLE 21 TRAINING & CONSULTING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)

8 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER (Page No. - 87)
    8.1 INTRODUCTION
          TABLE 22 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
    8.2 HOSPITALS
          TABLE 23 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 24 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION)
           8.2.1 LARGE HOSPITALS
                    8.2.1.1 Growing need to deploy cloud-based solutions to drive the growth of this market segment
                                TABLE 25 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LARGE HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION)
           8.2.2 MEDIUM-SIZED HOSPITALS
                    8.2.2.1 Increasing demand for more specialized and advanced care to boost the growth of this market segment
                                TABLE 26 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR MEDIUM-SIZED HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION)
           8.2.3 SMALL HOSPITALS
                    8.2.3.1 Growing need to decrease operational costs and increasing market competition to drive the growth of this market segment
                                TABLE 27 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR SMALL HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION)
    8.3 LONG-TERM CARE FACILITIES
          TABLE 28 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 29 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2019–2026 (USD MILLION)
           8.3.1 NURSING HOMES
                    8.3.1.1 Growing geriatric population to drive the growth of this market segment
                                TABLE 30 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR NURSING HOMES, BY COUNTRY, 2019–2026 (USD MILLION)
           8.3.2 SKILLED NURSING FACILITIES
                    8.3.2.1 Advancements in healthcare IT solutions to drive the growth of this market segment
                                TABLE 31 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR SKILLED NURSING FACILITIES, BY COUNTRY, 2019–2026 (USD MILLION)
           8.3.3 ASSISTED LIVING FACILITIES
                    8.3.3.1 Growing geriatric population and the increasing need for quality care to drive the growth of this market segment
                                TABLE 32 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR ASSISTED LIVING FACILITIES, BY COUNTRY, 2019–2026 (USD MILLION)
    8.4 OTHER END USERS
          FIGURE 28 US: SURGICAL PROCEDURAL VOLUME, BY SETTING: AMBULATORY SURGERY CENTERS VS. HOSPITALS (2005–2020)
          TABLE 33 INFECTION SURVEILLANCE SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)

9 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION (Page No. - 100)
    9.1 INTRODUCTION
          FIGURE 29 INFECTION SURVEILLANCE SOLUTIONS MARKET: GEOGRAPHIC SNAPSHOT (2021-2026)
          TABLE 34 INFECTION SURVEILLANCE SOLUTIONS MARKET, BY REGION, 2019–2026 (USD MILLION)
    9.2 IMPACT OF COVID-19 ON THE INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY/REGION
    9.3 NORTH AMERICA
          FIGURE 30 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET SNAPSHOT
          TABLE 35 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 36 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
          TABLE 37 NORTH AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 38 NORTH AMERICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 39 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
          TABLE 40 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 41 NORTH AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)
           9.3.1 US
                    9.3.1.1 Advanced medical infrastructure and increasing healthcare expenditure to drive the market growth
                                TABLE 42 US: KEY MACROINDICATORS
                                TABLE 43 US: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                TABLE 44 US: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 45 US: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 46 US: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                TABLE 47 US: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 48 US: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)
           9.3.2 CANADA
                    9.3.2.1 Growing adoption of technologically advanced HCIT solutions to propel market growth in Canada
                                TABLE 49 CANADA: KEY MACROINDICATORS
                                TABLE 50 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                TABLE 51 CANADA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 52 CANADA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 53 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                TABLE 54 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 55 CANADA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)
    9.4 EUROPE
          TABLE 56 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
          TABLE 57 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
          TABLE 58 EUROPE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 59 EUROPE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 60 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
          TABLE 61 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
          TABLE 62 EUROPE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)
           9.4.1 GERMANY
                    9.4.1.1 Increasing healthcare expenditure and growing adoption of healthcare IT solutions to drive market growth in Germany
                                TABLE 63 GERMANY: KEY MACROINDICATORS
                                TABLE 64 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                TABLE 65 GERMANY: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 66 GERMANY: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 67 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                TABLE 68 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 69 GERMANY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)
           9.4.2 FRANCE
                    9.4.2.1 High healthcare spending and favorable government initiatives to drive market growth in France
                                TABLE 70 FRANCE: KEY MACROINDICATORS
                                TABLE 71 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                TABLE 72 FRANCE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 73 FRANCE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 74 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                TABLE 75 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 76 FRANCE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)
           9.4.3 UK
                    9.4.3.1 Rising number of surgeries and implementation of favorable government initiatives to drive market growth in the UK
                                TABLE 77 UK: KEY MACROINDICATORS
                                TABLE 78 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                TABLE 79 UK: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 80 UK: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 81 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                TABLE 82 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 83 UK: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)
           9.4.4 ITALY
                    9.4.4.1 Increasing adoption of eHealth technologies to propel market growth in Italy
                                TABLE 84 ITALY: KEY MACROINDICATORS
                                TABLE 85 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                TABLE 86 ITALY: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 87 ITALY: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 88 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                TABLE 89 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 90 ITALY: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)
           9.4.5 SPAIN
                    9.4.5.1 Increasing focus on improving the healthcare infrastructure and growing number of COVID-19 cases to support the market growth
                                TABLE 91 SPAIN: KEY MACROINDICATORS
                                TABLE 92 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                TABLE 93 SPAIN: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 94 SPAIN: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 95 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                TABLE 96 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 97 SPAIN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)
           9.4.6 SWITZERLAND
                    9.4.6.1 Increasing demand for healthcare services and growing healthcare awareness to drive market growth
                                TABLE 98 SWITZERLAND: KEY MACROINDICATORS
                                TABLE 99 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                TABLE 100 SWITZERLAND: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 101 SWITZERLAND: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 102 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                TABLE 103 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 104 SWITZERLAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)
           9.4.7 NETHERLANDS
                    9.4.7.1 Increasing healthcare initiatives to drive market growth in the Netherlands
                                TABLE 105 NETHERLANDS: KEY MACROINDICATORS
                                TABLE 106 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                TABLE 107 NETHERLANDS: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 108 NETHERLANDS: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 109 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                TABLE 110 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 111 NETHERLANDS: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)
           9.4.8 REST OF EUROPE
                    TABLE 112 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                    TABLE 113 ROE: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 114 ROE: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 115 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                    TABLE 116 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 117 ROE: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)
    9.5 ASIA PACIFIC
             FIGURE 31 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET SNAPSHOT
             TABLE 118 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
             TABLE 119 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
             TABLE 120 ASIA PACIFIC: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 121 ASIA PACIFIC: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 122 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
             TABLE 123 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
             TABLE 124 ASIA PACIFIC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)
           9.5.1 JAPAN
                    9.5.1.1 Increasing geriatric population to drive market growth in Japan
                                TABLE 125 JAPAN: KEY MACROINDICATORS
                                TABLE 126 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                TABLE 127 JAPAN: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 128 JAPAN: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 129 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                TABLE 130 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 131 JAPAN: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)
           9.5.2 CHINA
                    9.5.2.1 Healthcare infrastructure improvements in China to drive the market growth
                                TABLE 132 CHINA: KEY MACROINDICATORS
                                TABLE 133 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                TABLE 134 CHINA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 135 CHINA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 136 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                TABLE 137 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 138 CHINA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)
           9.5.3 INDIA
                    9.5.3.1 Increasing demand for healthcare IT solutions to drive market growth in India
                                TABLE 139 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                TABLE 140 INDIA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 141 INDIA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 142 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                TABLE 143 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 144 INDIA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)
           9.5.4 AUSTRALIA AND NEW ZEALAND
                    9.5.4.1 Increasing number of hospitalizations and government initiatives for infection prevention to drive market growth in ANZ
                                TABLE 145 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                TABLE 146 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 147 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 148 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                TABLE 149 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 150 AUSTRALIA & NEW ZEALAND: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)
           9.5.5 SOUTH KOREA
                    9.5.5.1 Increasing medical tourism to drive market growth in South Korea
                                TABLE 151 SOUTH KOREA: KEY MACROINDICATORS
                                TABLE 152 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                                TABLE 153 SOUTH KOREA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 154 SOUTH KOREA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 155 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                                TABLE 156 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
                                TABLE 157 SOUTH KOREA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)
           9.5.6 REST OF ASIA PACIFIC
                    TABLE 158 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                    TABLE 159 ROAPAC: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 160 ROAPAC: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 161 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                    TABLE 162 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 163 ROAPAC: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)
    9.6 LATIN AMERICA
           9.6.1 HEALTHCARE IT INITIATIVES TO DRIVE MARKET GROWTH IN THE REGION
                    TABLE 164 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                    TABLE 165 LATIN AMERICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 166 LATIN AMERICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 167 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                    TABLE 168 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 169 LATIN AMERICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)
    9.7 MIDDLE EAST & AFRICA
           9.7.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND FOCUS ON SAFETY MEASURES TO DRIVE MARKET GROWTH
                    TABLE 170 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
                    TABLE 171 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOFTWARE MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 172 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 173 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION)
                    TABLE 174 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR HOSPITALS, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 175 MIDDLE EAST & AFRICA: INFECTION SURVEILLANCE SOLUTIONS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2019–2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 168)
     10.1 OVERVIEW
     10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE INFECTION SURVEILLANCE SOLUTIONS MARKET
     10.3 ADOPTION TRENDS FOR INNOVATIVE SOLUTIONS
     10.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
             FIGURE 32 REVENUE ANALYSIS OF KEY PLAYERS IN THE INFECTION SURVEILLANCE SOLUTIONS MARKET
     10.5 MARKET RANKING ANALYSIS
             TABLE 176 INFECTION SURVEILLANCE SOLUTIONS MARKET RANKING ANALYSIS, 2020
     10.6 COMPETITIVE BENCHMARKING
             TABLE 177 FOOTPRINT OF COMPANIES IN THE INFECTION SURVEILLANCE SOLUTIONS MARKET
             TABLE 178 PRODUCT & SERVICE FOOTPRINT OF COMPANIES (20 COMPANIES)
             TABLE 179 END-USER FOOTPRINT OF COMPANIES (20 COMPANIES)
             TABLE 180 REGIONAL FOOTPRINT OF COMPANIES (20 COMPANIES)
     10.7 COMPETITIVE LEADERSHIP MAPPING
             10.7.1 STARS
             10.7.2 EMERGING LEADERS
             10.7.3 PERVASIVE PLAYERS
             10.7.4 PARTICIPANTS
                        FIGURE 33 INFECTION SURVEILLANCE SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
     10.8 COMPETITIVE LEADERSHIP MAPPING FOR OTHER COMPANIES
             10.8.1 PROGRESSIVE COMPANIES
             10.8.2 DYNAMIC COMPANIES
             10.8.3 STARTING BLOCKS
             10.8.4 RESPONSIVE COMPANIES
                        FIGURE 34 INFECTION SURVEILLANCE SOLUTIONS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR OTHER COMPANIES (2020)
     10.9 COMPETITIVE SCENARIO
             10.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
                        TABLE 181 PRODUCT/SERVICE LAUNCHES/APPROVALS/ENHANCEMENTS, 2018–2021
             10.9.2 DEALS
                        TABLE 182 DEALS, 2018–2021
             10.9.3 OTHER DEVELOPMENTS
                        TABLE 183 OTHER DEVELOPMENTS, 2018–2021

11 COMPANY PROFILES (Page No. - 184)
     11.1 KEY PLAYERS
(Business Overview, Products & Services, Key Insights, Recent Developments, MnM View)*
             11.1.1 BECTON, DICKINSON AND COMPANY
                        TABLE 184 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
                        FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
             11.1.2 CERNER CORPORATION
                        TABLE 185 CERNER CORPORATION: BUSINESS OVERVIEW
                        FIGURE 36 CERNER CORPORATION: COMPANY SNAPSHOT (2020)
             11.1.3 PREMIER, INC.
                        TABLE 186 PREMIER, INC.: BUSINESS OVERVIEW
                        FIGURE 37 PREMIER, INC.: COMPANY SNAPSHOT (2021)
             11.1.4 IBM CORPORATION
                        TABLE 187 IBM CORPORATION: BUSINESS OVERVIEW
                        FIGURE 38 IBM CORPORATION: COMPANY SNAPSHOT (2020)
             11.1.5 BAXTER INTERNATIONAL INC.
                        TABLE 188 BAXTER INTERNATIONAL INC.: BUSINESS OVERVIEW
                        FIGURE 39 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2020)
             11.1.6 GOJO INDUSTRIES, INC.
                        TABLE 189 GOJO INDUSTRIES, INC.: BUSINESS OVERVIEW
             11.1.7 RLDATIX
                        TABLE 190 RLDATIX: BUSINESS OVERVIEW
             11.1.8 WOLTERS KLUWER N.V.
                        TABLE 191 WOLTERS KLUWER N.V.: BUSINESS OVERVIEW
                        FIGURE 40 WOLTERS KLUWER N.V.: COMPANY SNAPSHOT (2020)
             11.1.9 VIGILANZ CORPORATION
                        TABLE 192 VIGILANZ CORPORATION: BUSINESS OVERVIEW
             11.1.10 DEB GROUP LTD. (SUBSIDIARY OF S.C. JOHNSON & SON, INC.)
                        TABLE 193 DEB GROUP LTD.: BUSINESS OVERVIEW
             11.1.11 SUNQUEST INFORMATION SYSTEMS (SUBSIDIARY OF ROPER TECH.)
                        TABLE 194 SUNQUEST INFORMATION SYSTEMS: BUSINESS OVERVIEW
             11.1.12 BIOVIGIL HEALTHCARE SYSTEMS INC.
                        TABLE 195 BIOVIGIL HEALTHCARE SYSTEMS INC.: BUSINESS OVERVIEW
             11.1.13 ECOLAB INC.
                        TABLE 196 ECOLAB INC.: BUSINESS OVERVIEW
                        FIGURE 41 ECOLAB INC.: COMPANY SNAPSHOT (2020)
             11.1.14 VECNA TECHNOLOGIES
                        TABLE 197 VECNA TECHNOLOGIES: BUSINESS OVERVIEW
             11.1.15 BIOMΙRIEUX SA (SUBSIDIARY OF INSTITUT MERIEUX & SOFINA )
                        TABLE 198 BIOMΙRIEUX SA: BUSINESS OVERVIEW
                        FIGURE 42 BIOMΙRIEUX SA: COMPANY SNAPSHOT (2020)
             11.1.16 HARRIS HEALTHCARE GROUP (SUBSIDIARY OF N. HARRIS COMPUTER CORPORATION)
                        TABLE 199 HARRIS HEALTHCARE GROUP: BUSINESS OVERVIEW
             11.1.17 PERAHEALTH INC.
                        TABLE 200 PERAHEALTH INC.: BUSINESS OVERVIEW
             11.1.18 MEDEXTER HEALTHCARE GMBH
                        TABLE 201 MEDEXTER HEALTHCARE GMBH: BUSINESS OVERVIEW
             11.1.19 CENTRAK, INC. (SUBSIDIARY OF HALMA PLC)
                        TABLE 202 CENTRAK, INC.: BUSINESS OVERVIEW
             11.1.20 CKM HEALTHCARE INCORPORATED
                        TABLE 203 CKM HEALTHCARE INCORPORATED: BUSINESS OVERVIEW
*Details on Business Overview, Products & Services, Key Insights, Recent Developments, MnM View might not be captured in case of unlisted companies.
     11.2 OTHER PLAYERS
             11.2.1 ASOLVA INC.: COMPANY OVERVIEW
             11.2.2 POINTCLICKCARE: COMPANY OVERVIEW
             11.2.3 STANLEY HEALTHCARE: COMPANY OVERVIEW
             11.2.4 VITALACY, INC.: COMPANY OVERVIEW
             11.2.5 VIZZIA TECHNOLOGIES: COMPANY OVERVIEW

12 APPENDIX (Page No. - 234)
     12.1 INSIGHTS FROM INDUSTRY EXPERTS
     12.2 DISCUSSION GUIDE
     12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.4 AVAILABLE CUSTOMIZATIONS
     12.5 RELATED REPORTS
     12.6 AUTHOR DETAILS

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

This research study involved the use of comprehensive secondary sources; directories and databases such as D&B, Bloomberg Business, and Factiva; and white papers, annual reports, and company house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global infection surveillance solutions market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, technology perspectives, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the infection surveillance solutions market. The primary sources from the demand side include key executives from hospitals, long-term care facilities, ambulatory care settings, imaging and diagnostic services, assisted living facilities and research laboratories.

A breakdown of the primary respondents is provided below:

Infection Surveillance Solutions Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by product & service, end user, and region).

Data Triangulation

After arriving at the market size, the total infection surveillance solutions market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.

Objectives of the Study

  • To define, describe, segment, and forecast the infection surveillance solutions market by product & services, end – users and by region.
  • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall infection surveillance solutions market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the infection surveillance solutions market in five main regions (along with their respective key countries), namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players in the infection surveillance solutions market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, partnerships, and R&D activities of the leading players in the infection surveillance solutions market
  • To benchmark players within the infection surveillance solutions market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

Geographic Analysis

  • Further breakdown of the Latin American infection surveillance solutions market into Brazil, Mexico, and other Latin American countries.
  • Further breakdown of the MEA (Middle East & Africa) infection surveillance solutions market into the UAE, Saudi Arabia, and other MEA countries
COVID-19

Get in-depth analysis of the COVID-19 impact on the Infection Surveillance Solutions Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Infection Surveillance Solutions Market

Request For Special Pricing
Report Code
HIT 4380
Published ON
Sep, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Infection Surveillance Solutions Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved